Ecosse L. Lamoureux
National University of Singapore
518 Papers
1.9K Citations
Ecosse L. Lamoureux is an academic researcher from National University of Singapore. The author has contributed to research in topics: Medicine & Population. The author has an hindex of 57, co-authored 467 publications. Previous affiliations of Ecosse L. Lamoureux include Singapore National Eye Center & Sun Yat-sen University.
Chat about Author
Papers
Evaluating the outcome of screening for glaucoma using colour fundus photography-based referral criteria in a teleophthalmology screening programme for diabetic retinopathy.
Rose Tan,Kelvin CY Teo,Rahat Husain,Ngiap Chuan Tan,Qian Xin Lee,Haslina Hamzah,Tina Wong,Tin Aung,C. Cheng,Ecosse L. Lamoureux,Colin S Tan,H. Wong,T. Y. Wong,Gavin Siew Wei Tan +13 more
TL;DR: Opportunistic screening for glaucoma in a lower VCDR group could result in a high number of unnecessary referrals and targeting case findings on a largerVCDR group with high specificity will still be beneficial.
3
Patient Reported Symptoms Demonstrating an Association with Severity of Visual Field Damage in Glaucoma.
Yesha S. Shah,Michael Cheng,Aleksandra Mihailovic,Eva K Fenwick,Ecosse L. Lamoureux,Pradeep Y. Ramulu +5 more
TL;DR: In this article, patients rated their visual symptoms on questions collated from several published questionnaires, rating the frequency and severity of 28 symptoms on a scale of 1 (never/not at all) to 4 (very often/severe). Multivariable regression models identified patient reported symptoms that contributed the highest variance in VF damage.
3
Trial to Incentivise Adherence for Diabetes (TRIAD): study protocol for a randomised controlled trial.
Marcel Bilger,Mitesh Shah,Ngiap Chuan Tan,Kaye L. Howard,Hui Yan Xu,Ecosse L. Lamoureux,Eric A. Finkelstein,Eric A. Finkelstein +7 more
TL;DR: This study tests whether adding financial incentives to usual care can improve HbA1c levels among people with diabetes and whether the financial incentives work better when targeting processes or the primary intermediary health outcome of self-monitored blood glucose within an acceptable range.